Failure of prophylactic zinc in Wilson disease
Devendra Mishra1, Veena Kalra, Rachna Seth
1Child Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110 029, India.
Abstract:
Early institution of prophylactic therapy of asymptomatic Wilson disease patients can prevent the expression of the disease. Zinc is currently preferred therapy for presymptomatic patients. We report onset of symptomatic disease in a presymptomatic patient and deterioration of biochemical parameters in another, despite appropriate zinc therapy.
Related Concept Videos
Antiprotozoal Agents
Vitamins
Corrosion
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Psychosis: Goals of Pharmacotherapy
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment


